Table 1. Mean, standard deviation of baseline characteristics among two intervention and placebo groups before intervention .
Variable | Category | Group | p | |
Vitamin D (N=42) |
Placebo (N=43) |
|||
Age (Y) | - | 50.36 (10.2) | 5.05 (10.7) | 0.892* |
Weight (kg) | - | 77.38 (10.9) | 79.27 (11.6) | 0.442* |
Height (cm) | - | 159.35 (8.0) | 158.77 (7.6) | 0.736* |
BMI | - | 30.43 (3.2) | 31.37 (3.4) | 0.194* |
Disease period (months) | - | 65.52 (38.5) | 67.02 (35.4) | 0.664* |
Medication & daily dose | Metformin (500 mg) | 2.11 (1.13) | 2.51 (1.26) | 0.135* |
Glibenclamide (5mg) | 1.31 (0.94) | 0.95 (0.78) | ||
Sex | Male | 7.00 (16.7) | 8.00 (18.6) | 0.815** |
Female | 35.00 (83.3) | 35.00 (81.4) | ||
employment | Unemployed | 32.00 (76.2) | 32.00 (74.4) | 0.850** |
Employed | 10.00 (23.8) | 11.00 (25.6) |
Y: Year, kg: Kilo gram, cm: centimeter, BMI: Body Mass Index, mg: milligram, * Independent t-test, **Chi-squaretest